How Wegovy and Mounjaro Doses Compare for Online Prescriptions
Online Prescription Process for Wegovy and Mounjaro Doses
Getting prescribed Wegovy and Mounjaro doses online eliminates the traditional barriers of GP referrals and lengthy waiting times. Our 3-minute clinical assessment covers your medical history, current BMI, contraindications, and weight management goals to determine suitability for either treatment. Licensed UK prescribers review every application individually, ensuring both Wegovy's GLP-1 mechanism and Mounjaro's dual GIP + GLP-1 action are considered against your clinical profile. Express reviews are completed within 24 hours, while standard assessments take up to 3 working days.
The online prescription model provides access to both treatments through the same streamlined process. Whether you're considering Wegovy's established semaglutide formulation or Mounjaro's newer tirzepatide compound, our prescribers evaluate eligibility using identical clinical criteria. This ensures you receive the most appropriate treatment without the complexity of multiple referral pathways. Both medications require the same commitment to reduced-calorie diet and increased physical activity alongside treatment.
Wegovy and Mounjaro Doses: Pricing and Bundle Options
Wegovy doses start at £79.99 for the 0.25mg starter pen, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. Our Getting Started bundles combine sequential doses for convenience - the Intro Duo (0.25mg & 0.5mg) costs £169.99, while the Progress Trio (0.5mg, 1mg & 1.7mg) provides three months of escalation for £369.99. New customers apply code FIRST40 at checkout, while returning patients use DOSE25 to access these prices. Mounjaro pricing follows a similar structure with dose-specific pricing available through the same online prescription pathway.
Bundle options eliminate the need for multiple prescriptions during dose escalation phases. The Ultimate Stability Trio provides three 2.4mg Wegovy pens for £649.99, ensuring uninterrupted maintenance therapy. Take-it-Slow bundles accommodate patients who prefer extended periods at lower doses - the Gentle Start Trio includes two 0.25mg pens plus one 0.5mg for £269.99. Both Wegovy and Mounjaro doses benefit from the same discount structure and bundle convenience through EverydayMeds.
Clinical Evidence for Wegovy and Mounjaro Doses
In clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in the STEP 1 trial (Wilding et al., NEJM, 2021), compared to 2.4% with placebo. The STEP programme demonstrated consistent efficacy across the full dose escalation schedule from 0.25mg through to 2.4mg maintenance. Mounjaro's SURMOUNT trials showed the tirzepatide mechanism may offer additional benefits through its dual GIP + GLP-1 action, though direct head-to-head comparisons weren't conducted due to different trial designs.
Both Wegovy and Mounjaro doses require careful escalation to minimise gastrointestinal side effects while optimising efficacy. The evidence supports gradual dose increases every four weeks, allowing patients to adapt to each medication's appetite-suppressing effects. Long-term data from STEP 5 showed sustained weight loss at two years with continued Wegovy treatment, emphasising that both medications work best as part of ongoing lifestyle interventions.
How Wegovy Works: GLP-1 Mechanism for Dose Escalation
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural incretin hormone produced in your intestines after eating. This hormone targets specific receptors in your brain's appetite centres, promoting feelings of fullness and reducing food cravings between meals. The medication also slows gastric emptying, meaning food stays in your stomach longer and you feel satisfied with smaller portions. Starting with low Wegovy doses allows your body to gradually adapt to these appetite changes without overwhelming gastrointestinal effects. The systematic dose escalation from 0.25mg to 2.4mg maximises therapeutic benefit while minimising side effects that could interrupt treatment.
Ordering Process: From Assessment to Delivery
Complete your clinical assessment in approximately 3 minutes, covering medical history, current medications, BMI calculation, and treatment preferences for Wegovy and Mounjaro doses. Our licensed prescribers (GPhC #9012878) review your application within 3 working days, or within 24 hours if you select express review at checkout. Once approved, your prescription-only medicine is dispensed from our GPhC-registered pharmacy and dispatched via next-day delivery with full cold-chain temperature monitoring. You'll receive tracking information and delivery confirmation, ensuring your medication arrives in optimal condition. The entire process from assessment to delivery typically completes within 4-5 working days, or 2-3 days with express review selected.
Storage and Practical Considerations for Wegovy and Mounjaro Doses
Both Wegovy and Mounjaro require refrigeration at 2-8°C before first use, but Wegovy offers superior travel convenience with 6 weeks room temperature stability versus Mounjaro's 21 days below 30°C. The FlexTouch pen design used for Wegovy doses provides precise injection delivery with clear dose indicators and automatic needle safety features. Each pen contains four doses for once-weekly administration, with the medication remaining stable throughout the month-long usage period. Proper storage ensures consistent medication potency across all dose levels, from starter 0.25mg through to maintenance 2.4mg injections. Both treatments follow identical injection techniques and rotation sites, making the transition between medications straightforward if your prescriber recommends switching.
Dual-Pathway Assessment for Wegovy and Mounjaro Doses Online
EverydayMeds offers the unique advantage of prescriber assessment for both Wegovy and Mounjaro doses through a single consultation process. Our clinical team evaluates your suitability for semaglutide's pure GLP-1 action versus tirzepatide's dual GIP + GLP-1 mechanism based on your medical history and treatment goals. This comparative approach ensures you receive the most appropriate medication without requiring separate consultations for each option. Your prescriber considers factors like previous GLP-1 experience, diabetes status, cardiovascular history, and individual response predictions when recommending between treatments.
The dual-pathway assessment eliminates the guesswork often associated with choosing between these prescription-only medicines. Rather than selecting a medication before consultation, your clinical assessment determines which treatment mechanism - Wegovy's established GLP-1 action or Mounjaro's newer dual approach - aligns best with your physiology and weight management objectives. Both medications are available through the same streamlined ordering process, with identical delivery timelines and clinical support throughout treatment.
Secure Your Wegovy and Mounjaro Doses with Expert Clinical Support
Both Wegovy and Mounjaro are available from EverydayMeds with comprehensive prescriber guidance throughout your dose escalation journey. New customers use code FIRST40 at checkout, while returning patients apply DOSE25 to access our competitive pricing structure starting from £79.99. Your licensed prescriber remains available for dose adjustment consultations, side effect management, and treatment optimisation as you progress through the escalation schedule. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment and discover which treatment suits your weight management needs. With GPhC #9012878 registration and MHRA-approved supply chains, we ensure both medications reach you with assured potency and cold-chain integrity throughout delivery.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
